Friedenthal Financial Makes New $50,000 Investment in HCA Healthcare, Inc. (NYSE:HCA)

Friedenthal Financial bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 123 shares of the company’s stock, valued at approximately $50,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Bangor Savings Bank boosted its holdings in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the second quarter worth approximately $28,000. GPS Wealth Strategies Group LLC raised its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new position in HCA Healthcare in the second quarter worth $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Up 2.2 %

Shares of HCA stock opened at $415.54 on Friday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $417.14. The company has a 50 day simple moving average of $392.18 and a two-hundred day simple moving average of $350.34. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $108.84 billion, a P/E ratio of 20.71, a P/E/G ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.29 earnings per share. On average, research analysts expect that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were issued a dividend of $0.66 per share. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.64%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the transaction, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,202 shares of company stock worth $6,407,273. 1.60% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have issued reports on HCA shares. Leerink Partners upped their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target for the company. Barclays boosted their target price on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research note on Tuesday, July 30th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $365.65.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.